Granules India offers multiple finished dosage forms, comprising tablets, caplets and press-fit capsules in bulk, blister packs and bottles.

We provide unique rapid release tablets, bilayer tablets and extended release (ER) tablets, strengthening the competitive advantage of customers. We have our own ANDAs and dossiers, which enable customers to enter related markets easily.

We also have a dedicated team for site-transfer related projects. We are the only Indian pharmaceutical player to manufacture ‘pressfit’ (rapid release tablets) dosages and are among the few to manufacture bi-layered tablets.

At GPI, our objective is to focus on formulation R&D and low volume manufacturing by leveraging a niche technology that enables us to make dosage forms with specific release capabilities like pulsatile drug release in tablet and capsule dosage form , orally disintegrating modified release tablets (XR, MR, ER), modified release suspension and controlled substances capabilities in an abuse deterrent technology platform .